Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
“Multiple inflammatory, oxidative, and microbial targets" refers to the collection of biological molecules—including receptors, enzymes, and signaling intermediates—involved in inflammatory responses, oxidative stress, and defense against microbial infection. This phrase is used to describe the broad therapeutic strategies aimed at modulating these interrelated processes in complex diseases such as cardiovascular disorders, neurodegenerative diseases, cancer, and infections. Because this is a summary category, it does not correspond to a unique molecular entity and should not be used as a canonical drug target.
Inhibition of reactive oxygen species (ROS) generation; Modulation of inflammatory cytokine signaling pathways (e.g., NF-κB, MAPK); Direct antimicrobial activity
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple inflammatory, oxidative, and microbial targets.